Laddar...
Changes in Hematologic Parameters during Treatment with Medroxyprogesterone Acetate for Breast Cancer
To elucidate the etiology of the thrombogenic effects of high‐dose medroxyprogesterone acetate (MPA) in the treatment of breast cancer, hematologic parameters were sequentially assessed in 12 patients receiving MPA 800 mg p.o. daily for 6 months as adjuvant hormone therapy after mastectomy. The resu...
Sparad:
| I publikationen: | Jpn J Cancer Res |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Blackwell Publishing Ltd
1991
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5918452/ https://ncbi.nlm.nih.gov/pubmed/1828463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1991.tb01865.x |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|